Selected research
Industry Research
Acamprosate Industry Research Report 2026
Market perspective
The global Acamprosate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Acamprosate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Acamprosate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Acamprosate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Acamprosate include Teva, Merck Group, Mylan, Zydus Pharmaceuticals and Glenmark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Acamprosate market in terms of revenue (US$ million) and, where applicable, sales volume (K Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Acamprosate Market by Company
Teva
Merck Group
Mylan
Zydus Pharmaceuticals
Glenmark Pharmaceuticals
Acamprosate Segment by Type
333 mg Delayed Release Tablet
Others
Acamprosate Segment by Application
Hospital
Clinic
Others
Acamprosate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acamprosate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acamprosate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acamprosate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Acamprosate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Acamprosate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Acamprosate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 333 mg Delayed Release Tablet
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Teva
- Merck Group
- Mylan
- Zydus Pharmaceuticals
- Glenmark Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Acamprosate Market Size (2021-2032)
- 2.2.2 Global Acamprosate Sales (2021-2032)
- 2.2.3 Global Acamprosate Market Average Price (2021-2032)
- 2.3 Acamprosate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 333 mg Delayed Release Tablet
- 2.3.3 Others
- 2.4 Acamprosate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Acamprosate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Acamprosate Sales (K Pcs) of Manufacturers (2021-2026)
- 3.3 Global Acamprosate Revenue of Manufacturers (2021-2026)
- 3.4 Global Acamprosate Average Price by Manufacturers (2021-2026)
- 3.5 Global Acamprosate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Acamprosate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Acamprosate, Product Type & Application
- 3.8 Global Manufacturers of Acamprosate, Established Date
- 3.9 Global Acamprosate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Acamprosate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Acamprosate Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Merck Group
- 4.2.1 Merck Group Company Information
- 4.2.2 Merck Group Business Overview
- 4.2.3 Merck Group Acamprosate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck Group Acamprosate Product Portfolio
- 4.2.5 Merck Group Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Acamprosate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Acamprosate Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Zydus Pharmaceuticals
- 4.4.1 Zydus Pharmaceuticals Company Information
- 4.4.2 Zydus Pharmaceuticals Business Overview
- 4.4.3 Zydus Pharmaceuticals Acamprosate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zydus Pharmaceuticals Acamprosate Product Portfolio
- 4.4.5 Zydus Pharmaceuticals Recent Developments
- 4.5 Glenmark Pharmaceuticals
- 4.5.1 Glenmark Pharmaceuticals Company Information
- 4.5.2 Glenmark Pharmaceuticals Business Overview
- 4.5.3 Glenmark Pharmaceuticals Acamprosate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Glenmark Pharmaceuticals Acamprosate Product Portfolio
- 4.5.5 Glenmark Pharmaceuticals Recent Developments
5 Global Acamprosate Market Scenario by Region
- 5.1 Global Acamprosate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Acamprosate Sales by Region: 2021-2032
- 5.2.1 Global Acamprosate Sales by Region: 2021-2026
- 5.2.2 Global Acamprosate Sales by Region: 2027-2032
- 5.3 Global Acamprosate Revenue by Region: 2021-2032
- 5.3.1 Global Acamprosate Revenue by Region: 2021-2026
- 5.3.2 Global Acamprosate Revenue by Region: 2027-2032
- 5.4 North America Acamprosate Market Facts & Figures by Country
- 5.4.1 North America Acamprosate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Acamprosate Sales by Country (2021-2032)
- 5.4.3 North America Acamprosate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Acamprosate Market Facts & Figures by Country
- 5.5.1 Europe Acamprosate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Acamprosate Sales by Country (2021-2032)
- 5.5.3 Europe Acamprosate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Acamprosate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Acamprosate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Acamprosate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Acamprosate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Acamprosate Market Facts & Figures by Country
- 5.7.1 South America Acamprosate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Acamprosate Sales by Country (2021-2032)
- 5.7.3 South America Acamprosate Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Acamprosate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Acamprosate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Acamprosate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Acamprosate Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Acamprosate Sales by Type (2021-2032)
- 6.1.1 Global Acamprosate Sales by Type (2021-2032) & (K Pcs)
- 6.1.2 Global Acamprosate Sales Market Share by Type (2021-2032)
- 6.2 Global Acamprosate Revenue by Type (2021-2032)
- 6.2.1 Global Acamprosate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Acamprosate Revenue Market Share by Type (2021-2032)
- 6.3 Global Acamprosate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Acamprosate Sales by Application (2021-2032)
- 7.1.1 Global Acamprosate Sales by Application (2021-2032) & (K Pcs)
- 7.1.2 Global Acamprosate Sales Market Share by Application (2021-2032)
- 7.2 Global Acamprosate Revenue by Application (2021-2032)
- 7.2.1 Global Acamprosate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Acamprosate Revenue Market Share by Application (2021-2032)
- 7.3 Global Acamprosate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Acamprosate Value Chain Analysis
- 8.1.1 Acamprosate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Acamprosate Production Mode & Process
- 8.2 Acamprosate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Acamprosate Distributors
- 8.2.3 Acamprosate Customers
9 Global Acamprosate Analyzing Market Dynamics
- 9.1 Acamprosate Industry Trends
- 9.2 Acamprosate Industry Drivers
- 9.3 Acamprosate Industry Opportunities and Challenges
- 9.4 Acamprosate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst